Purification of El Tor cholera enterotoxins and comparisons with classical toxin

References

1. Black R. E. 1986; The epidemiology of cholera and enterotoxigenic E. coli diarrhoeal disease. In Development of Vaccines and Drugs against Diarrhoea (11th Nobel Conference, Stockholm 1985) pp. 23–32 Holmgren J., Lindberg A., Mollby R. Edited by Lund: Studentlitteratur;
   [Google Scholar]
2. Clemens J. D., Sack D. A., Vanloon F., Chakraborty J., Ahmed F., Rao M. R., Harris J. R., Khan M. R., Yunus M., Huda N., Stanton B. F., Kay B. A., Walter S., Eeckels R., Svennerholm A.-M., Holmgren J. 1990; Field trial of oral cholera vaccines in Bangladesh: results from long term follow-up. Lancet i:270–273
   [Google Scholar]
3. Craig J. P. 1965; A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature; London: 207614–616
   [Google Scholar]
4. Finkelstein R. A. 1984; Cholera. In Bacterial Vaccines pp. 107–136 Germanier R. Edited by New York: Academic Press;
   [Google Scholar]
5. Finkelstein R. A. 1969; Pathogenesis of experimental cholera: preparation and isolation of choleragen and choleragenoid. Journal of Experimental Medicine 130:185–202
   [Google Scholar]
6. Finkelstein R. A., Atthasampunna P., Chulasamaya M., Charunmethee P. 1966; Pathogenesis of experimental cholera: biological activities of purified choleragen A. Journal of Immunology 96:440–449
   [Google Scholar]
7. Holmgren J. 1973; Comparison of the tissue receptors for Vibrio chlorae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infection and Immunity 8:851–859
   [Google Scholar]
8. Holmgren J. 1981; Actions of cholera toxin and the prevention and treatment of cholera. Nature; London: 292413–417
   [Google Scholar]
9. Holmgren J., Månsson J. E., Svennerholm L. 1974; Tissue receptor for cholera exotoxin: structural requirements of GM, ganglioside in toxin binding and inactivation. Medical Biology 52:229–233
   [Google Scholar]
10. Holmgren J., Clemens J., Sack D. A., Svennerholm A.-M. 1989; New cholera vaccines. Vaccine 7:94–96
    [Google Scholar]
11. Iwanaga M., Yamamoto K. 1985; New medium for the production of cholera toxin by Vibrio cholerae 01 biotype El Tor. Journal of Clinical Microbiology 22:405–408
    [Google Scholar]
12. Iwanaga M., Kuyyakanond T. 1987; Large production of cholera toxin by Vibrio cholerae 01 in yeast extract peptone water. Journal of Clinical Microbiology 25:2314–2316
    [Google Scholar]
13. Iwanaga M., Yamamoto K., Higa N., Ichinose Y., Nakasone N., Tanabe M. 1986; Culture conditions for stimulating cholera toxin production by Vibrio cholerae 01 El Tor. Microbiology and Immunology 30:1075–1083
    [Google Scholar]
14. Kusama H., Craig J. P. 1970; Production of biologically active substances by two strains of Vibrio cholerae . Infection and Immunity 1:80–87
    [Google Scholar]
15. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
16. Lindholm L., Holmgren J., Wikström M., Karlsson U., Anderson K., Lycke N. 1983; Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat labile enterotoxin. Infection and Immunity 38:267–272
    [Google Scholar]
17. Lönnroth I., Holmgren J. 1973; Subunit structure of cholera toxin. Journal of General Microbiology 76:417–427
    [Google Scholar]
18. Marchlewicz B. A., Finkelstein R. A. 1983; Immunological differences among the cholera/coli family of enterotoxins. Diagnostics in Microbiology and Infectious Diseases 1:129–138
    [Google Scholar]
19. Mekalanos J. J., Collier R. J., Romig W. R. 1978; Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants. Infection and Immunity 20:552–558
    [Google Scholar]
20. Moss J., Vaughan M. 1977; Mechanism of action of choleragen. Evidence for ADP-ribosyl transferase activity with arginine as an acceptor. Journal of Biological Chemistry 252:2455–2457
    [Google Scholar]
21. Ouchterlony O., Nilsson L.-A. 1978; Immunodiffusion and immunoelectrophoresis. In Handbook of Experimental Immunology pp. 1–44 Weir D. M. Edited by Oxford: Blackwell;
    [Google Scholar]
22. Svennerholm A.-M., Holmgren J. 1986; Oral combined B subunit-whole cell cholera vaccine. In Development of Vaccines and Drugs against Diarrhoea (11th Nobel Conference, Stockholm 1985) pp. 33–43 Holmgren J., Lindberg A., Mollby R. Edited by Lund: Studentlitteratur;
    [Google Scholar]
23. Svennerholm A.-M., Strömberg G. J., Holmgren J. 1983; Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations. Infection and Immunity 41:237–243
    [Google Scholar]
24. Svennerholm A.-M., Wlkström M., Llndblad M., Holmgren J. 1986; Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Medical Biology 64:23–30
    [Google Scholar]
25. Tamplin M. L., Ahmed M. K., Jalali R., Colwell R. R. 1989; Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin. Journal of General Microbiology 135:1195–1200
    [Google Scholar]
26. Tayot J. L., Holmgren J., Svennerholm L., Lindblad M., Tardy M. 1981; Receptor specific large scale purification of cholera toxin on silica beads derivatized with lyso GM] ganglioside. European Journal of Biochemistry 113:249–258
    [Google Scholar]
27. Wadsworth C. 1957; A slide microtechnique for the analysis of immune precipitates in gel. International Archives of Allergy and Applied Immunology 10:335–360
    [Google Scholar]